The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.
Open accessAbstract
Immunohistochemistry is increasingly used in the assessment of markers for breast cancer prognosis. Semiquantitation is frequently desirable but, other than by the use of image analysis, the approaches currently in use are cumbersome. The most common method used is the H-score which takes into consideration the staining intensity in conjunction with the percentage of cells staining positively in breast carcinoma tissue. A "quickscore" has been developed which dispenses with the need to count individual cells. The quantitative biochemical Abbott enzyme immunoassay (EIA) and the Dako immunohistochemical assay (IHA) incorporating a semiquantitative H-score, have been used as standards against which the IHA quickscore for the semiquantitation of oestrogen receptor expression was tested. A good correlation was found between the quickscore and the EIA, which was as good as that between the H-score and EIA. The quickscore is a valid approach and there is no advantage in using the more rigorous H-score. A positive cut off quickscore of > or = 3 has been suggested.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barnes, D. M., Dublin, E. A., Fisher, C. J., Levison, D. A., & Millis, R. R. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90158-d · Cited by 221
Cited by
Fedchenko, N., & Reifenrath, J. (2014) · Diagnostic Pathology · doi:10.1186/s13000-014-0221-9 · Cited by 808
Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
Paschalis, A., Sheehan, B., Riisnaes, R., Rodrigues, D. N., Gurel, B., Bertan, C., Ferreira, A., Lambros, M. B. K., Seed, G., Yuan, W., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.06.030 · Cited by 455
Lee, H.-H., Wang, Y.-N., Xia, W., Chen, C.-H., Rau, K.-M., Ye, L., Wei, Y., Chou, C.-K., Wang, S.-C., Yan, M., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.06.008 · Cited by 405
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
Sharp, A., Coleman, I., Yuan, W., Sprenger, C., Dolling, D., Rodrigues, D. N., Russo, J. W., Figueiredo, I., Bertan, C., Seed, G., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci122819 · Cited by 393
Catenacci, D. V. T., Tebbutt, N. C., Davidenko, I., Murad, A. M., Al-Batran, S.-E., Ilson, D. H., Tjulandin, S., Gotovkin, E., Karaszewska, B., Bondarenko, I., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30566-1 · Cited by 348
Walker, R. A. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02514.x · Cited by 316
Lehr, H.-A., Mankoff, D. A., Corwin, D., Santeusanio, G., & Gown, A. M. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704501112 · Cited by 308
Hadad, S., Iwamoto, T., Jordan, L., Purdie, C., Bray, S., Baker, L., Jellema, G., Deharo, S., Hardie, D. G., Pusztai, L., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1612-1 · Cited by 293
Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer
Stoutjesdijk, M. J., Boetes, C., Jager, G. J., Beex, L., Bult, P., Hendriks, J. H. C. L., Laheij, R. J. F., Massuger, L., van Die, L. E., Wobbes, T., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1095 · Cited by 289
A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer
Girardini, J. E., Napoli, M., Piazza, S., Rustighi, A., Marotta, C., Radaelli, E., Capaci, V., Jordan, L., Quinlan, P., Thompson, A., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.004 · Cited by 286
Re: Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer
Goffin, J., Chappuis, P. O., Wong, N., & Foulkes, W. D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1754 · Cited by 284
Targeting the p300/CBP Axis in Lethal Prostate Cancer
Welti, J., Sharp, A., Brooks, N., Yuan, W., McNair, C., Chand, S. N., Pal, A., Figueiredo, I., Riisnaes, R., Gurel, B., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0751 · Cited by 275
Knight, D. A., Lim, S., Scaffidi, A. K., Roche, N., Chung, K. F., Stewart, G. A., & Thompson, P. J. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.119025 · Cited by 269
Mohseny, A. B., Szuhai, K., Romeo, S., Buddingh, E. P., Briaire‐de Bruijn, I., de Jong, D., van Pel, M., Cleton‐Jansen, A., & Hogendoorn, P. C. (2009) · The Journal of Pathology · doi:10.1002/path.2603 · Cited by 269
Puhr, M., Hoefer, J., Schäfer, G., Erb, H. H. H., Oh, S. J., Klocker, H., Heidegger, I., Neuwirt, H., & Culig, Z. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.08.011 · Cited by 263
Thompson, A. M., Jordan, L. B., Quinlan, P., Anderson, E., Skene, A., Dewar, J. A., Purdie, C. A., & the Breast Recurrence in Tissues Study Group (2010) · Breast Cancer Research · doi:10.1186/bcr2771 · Cited by 253
Understanding Coupling between Bone Resorption and Formation
Andersen, T. L., Abdelgawad, M. E., Kristensen, H. B., Hauge, E. M., Rolighed, L., Bollerslev, J., Kjærsgaard-Andersen, P., & Delaisse, J.-M. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.03.006 · Cited by 137
Concomitant inactivation of p53 and Chk2 in breast cancer
Sullivan, A., Yuille, M., Repellin, C., Reddy, A., Reelfs, O., Bell, A., Dunne, B., Gusterson, B. A., Osin, P., Farrell, P. J., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205207 · Cited by 91
“All normal epithelial elements and carcinomas were independently assessed using the quick score method (Detre et al., 1995).”
MethodJoshi, N. R., Miyadahira, E. H., Afshar, Y., Jeong, J.-W., Young, S. L., Lessey, B. A., Serafini, P. C., & Fazleabas, A. T. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2076 · Cited by 87
Abdelgawad, M. E., Delaisse, J.-M., Hinge, M., Jensen, P. R., Alnaimi, R. W., Rolighed, L., Engelholm, L. H., Marcussen, N., & Andersen, T. L. (2016) · Histochemistry and Cell Biology · doi:10.1007/s00418-016-1414-y · Cited by 76
High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival
Wang, Q., Ni, Q., Wang, X., Zhu, H., Wang, Z., & Huang, J. (2015) · Medical Oncology · doi:10.1007/s12032-014-0372-2 · Cited by 70
Estrogen and progesterone receptors in smooth muscle component of deep infiltrating endometriosis
Noël, J.-C., Chapron, C., Bucella, D., Buxant, F., Peny, M.-O., Fayt, I., Borghese, B., & Anaf, V. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.12.114 · Cited by 41
Wang, C., Mavrogianis, P. A., & Fazleabas, A. T. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.072496 · Cited by 30
Silva Servato, J. P., Ueira Vieira, C., de Faria, P. R., Cardoso, S. V., & Loyola, A. M. (2019) · Journal of Oral Pathology & Medicine · doi:10.1111/jop.12942 · Cited by 19
CAPER as a therapeutic target for triple negative breast cancer
Campbell, M. C., Pontiggia, L., Russell, A. Y., Schwarting, R., Camacho, J., Jasmin, J.-F., & Mercier, I. (2018) · Oncotarget · doi:10.18632/oncotarget.25719 · Cited by 10
Du, Y., Yan, H., Zou, S., Khera, T., Li, J., Han, M., Yang, X., Wang, B., Liu, J., Sun, S., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1676 · Cited by 9
Primavesi, F., Senoner, T., Schindler, S., Nikolajevic, A., Di Fazio, P., Csukovich, G., Eller, S., Neumayer, B., Anliker, M., Braunwarth, E., et al. (2024) · Antioxidants · doi:10.3390/antiox13050590 · Cited by 3
“5% Tween20 overnight at 4 ◦ C. UCP2 and 4-HNE were chosen as tissue oxidative stress markers as they represent both mitochondrial ROS production as well as cell membrane lipid phospholipid peroxidation and have shown significant results in previous liver function experimental studies [37,38].”
BackgroundMethod
Metadata
- Authors
- Detre, S., Saclani Jotti, G., & Dowsett, M.
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 1995-09
- Volume
- 48
- Issue
- 9
- Pages
- 876-878
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- OpenAlex
- W1967827870
- Cited by
- 880
- References
- 1
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.